Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.34
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.81% | 7.07% | -3.33% | -7.68% | -0.10% |
| Total Other Revenue | -19.77% | 19.92% | -- | -10.57% | 24.17% |
| Total Revenue | 9.76% | 7.14% | -3.33% | -7.72% | 0.08% |
| Cost of Revenue | 8.04% | 6.20% | -1.32% | -6.01% | 4.45% |
| Gross Profit | 19.60% | 12.54% | -10.41% | -18.05% | -19.29% |
| SG&A Expenses | 15.37% | 15.94% | -13.31% | 2.71% | -17.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -262.05% | 379.70% | 156.09% | 528.22% | 161.04% |
| Total Operating Expenses | 8.05% | 7.22% | -2.75% | -3.86% | 2.27% |
| Operating Income | 47.88% | 5.20% | -8.48% | -185.44% | -32.24% |
| Income Before Tax | 40.85% | 10.76% | -10.21% | -211.70% | -35.58% |
| Income Tax Expenses | 74.93% | 0.29% | -12.34% | -501.12% | -26.19% |
| Earnings from Continuing Operations | 32.34% | 13.08% | -9.76% | -187.65% | -37.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -135.83% | 47.21% | 51.54% | 47.26% | 55.01% |
| Net Income | 30.30% | 17.65% | -8.19% | -222.79% | -37.09% |
| EBIT | 47.88% | 5.20% | -8.48% | -185.44% | -32.24% |
| EBITDA | 37.51% | 3.13% | -8.70% | -130.99% | -25.92% |
| EPS Basic | 30.15% | 17.73% | -8.17% | -223.11% | -37.02% |
| Normalized Basic EPS | 61.36% | -2.68% | -7.61% | -238.02% | -37.54% |
| EPS Diluted | 30.15% | 17.73% | -8.17% | -223.11% | -37.02% |
| Normalized Diluted EPS | 61.36% | -2.68% | -7.61% | -238.02% | -37.54% |
| Average Basic Shares Outstanding | 0.06% | -0.06% | -0.01% | 0.07% | 0.01% |
| Average Diluted Shares Outstanding | 0.06% | -0.06% | -0.01% | 0.07% | 0.01% |
| Dividend Per Share | -- | 0.18% | -- | -46.38% | -- |
| Payout Ratio | 0.98% | -0.51% | 0.17% | -6.56% | 1.00% |